Evidence map›Paper›PMID 29490026›Full record

Observational studyClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Significant Patient Impact Observed Upon Implementation of Point-of-Care Early Infant Diagnosis Technologies in an Observational Study in Malawi.

Reuben Mwenda, Youyi Fong, Termson Magombo, Emmanuel Saka, Dalitso Midiani, Christopher Mwase, James Kandulu, Melody Wang, Rachel Thomas, Judith Sherman and 1 more

Abstract readObservational Study
In one paragraph

Observational study in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Reuben MwendaMinistry of Health, Lilongwe, Malawi.
Youyi FongFred Hutchinson Cancer Research Center, Seattle, Washington.
Termson MagomboClinton Health Access Initiative, Lilongwe, Malawi.
Emmanuel SakaUnited Nations Children's Fund, Lilongwe, Malawi.
Dalitso MidianiMinistry of Health, Lilongwe, Malawi.
Christopher MwaseClinton Health Access Initiative, Lilongwe, Malawi.
James KanduluMinistry of Health, Lilongwe, Malawi.
Melody WangClinton Health Access Initiative, Lilongwe, Malawi.
Rachel ThomasClinton Health Access Initiative, Lilongwe, Malawi.
Judith ShermanUnited Nations Children's Fund, Lilongwe, Malawi.
Lara VojnovClinton Health Access Initiative, Lilongwe, Malawi.

Funding

Statistical methods for HIV-1 immune correlates studiesR01AI122991 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI FONG, YOUYI · 2016 to 2020
$1.6M
NIAID NIH HHS R01 AI122991
6 · The paper itself

Abstract

Background: In Malawi in 2014, <20% of human immunodeficiency virus (HIV)-exposed infants received an early infant diagnosis (EID) test in the first 2 months of life and only 30% of HIV-infected children were on antiretroviral therapy (ART). We sought to understand the potential patient impact of improving timely infant diagnosis and treatment initiation through implementation of point-of-care (POC) EID technologies in Malawi. Methods: In this observational study, POC EID technologies were introduced into routine services at 7 health facilities across Malawi in September 2015. The primary outcome was the proportion of HIV-infected infants initiating ART within 60 days of sample collection in the POC arm compared to the baseline arm with conventional laboratory-based EID testing. Results: The time from sample collection to result received by the patient decreased significantly from 56 days (interquartile range [IQR], 30-81 days) in the baseline arm to <1 day in the POC arm (P < .001). Of the HIV-infected infants, the time between sample collection and ART initiation was reduced from 38 days (IQR, 30-54 days) in the baseline arm to <1 day (IQR, 0-1 day) in the POC arm (P = .019). Furthermore, the proportion of HIV-infected infants initiated on ART within 60 days of sample collection increased significantly from 41.9% to 91.1% after the introduction of POC (adjusted risk ratio, 2.28; P < .001). Conclusions: ART initiation rates were significantly improved with the implementation of same-day POC EID testing compared with referred, longer-turnaround laboratory-based testing.

Indexed as

Point-of-Care TestingTime-to-TreatmentAntiretroviral Therapy, Highly ActiveEarly DiagnosisFemaleHIV InfectionsHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalMalawiMaleOdds RatioTreatment Outcome

Identifiers

PMID29490026
PMCPMC6093992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.